Advertisement
UK markets close in 2 hours 11 minutes
  • FTSE 100

    7,864.70
    +16.71 (+0.21%)
     
  • FTSE 250

    19,374.33
    +34.19 (+0.18%)
     
  • AIM

    744.14
    +1.02 (+0.14%)
     
  • GBP/EUR

    1.1687
    +0.0020 (+0.17%)
     
  • GBP/USD

    1.2458
    +0.0002 (+0.01%)
     
  • Bitcoin GBP

    49,912.10
    -68.80 (-0.14%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • CRUDE OIL

    83.17
    +0.48 (+0.58%)
     
  • GOLD FUTURES

    2,399.60
    +11.20 (+0.47%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     
  • DAX

    17,770.83
    +0.81 (+0.00%)
     
  • CAC 40

    8,002.89
    +21.38 (+0.27%)
     

Company News For Oct 4, 2017

Ross Stores (ROST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
  • Shares of Lennar Corp. LEN surged 4.8% after posting third quarter 2017 earnings per share of $1.06, surpassing the Zacks Consensus Estimate of $1.01

  • Paychex, Inc.’s PAYX shares rallied 3.6% after reporting first quarter 2018 earnings per share of $0.62, surpassing the Zacks Consensus Estimate of $0.60

  • Shares of Wal-Mart WMT increased almost 1% after the company purchased Parcel — a New York based delivery startup

  • Myovant Sciences’ MYOV gained almost 10% after the company reported positive results from the Takeda study of its under development drug Relugolix


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Lennar Corporation (LEN) : Free Stock Analysis Report
 
Wal-Mart Stores, Inc. (WMT) : Free Stock Analysis Report
 
Paychex, Inc. (PAYX) : Free Stock Analysis Report
 
Myovant Sciences Ltd. (MYOV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research